CCRB Logo

Modification History

CUHK_CCT00095

A Randomized, Double Blind, Placebo Controlled Trial on the Effect of Rosiglitazone in Reversion of Newly Diagnosed Type 2 Diabetes to Non-Diabetic Status

2006-03-28

Update Date Recruitment Status Modified By  
2013-09-11 Complete Administrator Detail
2013-09-11 Complete Administrator Detail
2012-08-31 Complete Administrator Detail
2011-02-08 Complete Administrator Detail
2009-11-19 Complete Administrator Detail
2006-03-28 Complete Registry User Detail
Back